Inosine dialdehyde
Term · Oncology and biomedicine · MLC-T-ONC-014462
A toxic purine analogue. Inosine dialdehyde inhibits ribonucleotide reductase, resulting in decreased synthesis of DNA, RNA, and proteins, and G2/M-phase cell cycle arrest. This agent also forms stable covalent crosslinks in proteins, thereby inhibiting the activity of enzymes involved in nucleic acid synthesis.
| Identifier | MLC-T-ONC-014462 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | IdA |
| Synonyms | INOX; diglycoaldehyde |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-014462",
"term": "Inosine dialdehyde",
"field": "Oncology and biomedicine",
"definition": "A toxic purine analogue. Inosine dialdehyde inhibits ribonucleotide reductase, resulting in decreased synthesis of DNA, RNA, and proteins, and G2/M-phase cell cycle arrest. This agent also forms stable covalent crosslinks in proteins, thereby inhibiting the activity of enzymes involved in nucleic acid synthesis.",
"abbreviation": "IdA",
"synonyms": [
"INOX",
"diglycoaldehyde"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/inosine-dialdehyde/"
}
Record 9,287 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.